Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Blood|April 15, 2015
The biology and management of systemic anaplastic large cell lymphomaGreg Hapgood, Kerry J Savage
Thrombosis and Haemostasis|June 21, 2013
The effect of dabigatran on the activated partial thromboplastin time and thrombin time as determined by the Hemoclot thrombin inhibitor assay in patient plasma samplesGreg Hapgood, Jenny Butler, Erica Malan, et al.
Leukemia & Lymphoma|November 15, 2019
Trends in myeloma relative survival in Queensland by treatment era, age, place of residence, and socioeconomic statusMatthew Harwood, Nathan Dunn, Julie Moore, et al.
The Medical Journal of Australia|August 11, 2018
Relative survival of patients with lymphoma in Queensland according to histological subtypeFraser Wright, Greg Hapgood, Aravi Loganathan, et al.
Ejhaem|February 13, 2025
An Economic Evaluation of the TROG 99.03 Trial: Systemic Therapy After Radiotherapy in Early-Stage Follicular LymphomaDaniel Erku, Joshua W D Tobin, John F Seymour, et al.
Bioinformatics (Oxford, England)|December 23, 2016
Defining the clonality of peripheral T cell lymphomas using RNA-seqScott D Brown, Greg Hapgood, Christian Steidl, et al.
British Journal of Haematology|October 13, 2024
The value of semiquantitative PET features and end-of-therapy PET in grade 3B follicular lymphomaAllison Barraclough, Sze Ting Lee, Diego Villa, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 24, 2023
Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphomaVijay Mistry, Justin R Scott, Tzu-Yang Wang, et al.
Leukemia & Lymphoma|July 29, 2021
A cost-effectiveness analysis of front-line treatment strategies in early-stage follicular lymphomaJoshua W D Tobin, Anna Crothers, Ti Eric Ma, et al.
Leukemia & Lymphoma|December 15, 2018
A phase II study of a modified hyper-CVAD frontline therapy for patients with adverse risk diffuse large B-cell and peripheral T-cell non-Hodgkin lymphomaGreg Hapgood, Janey M Stone, Diana Zannino, et al.
Pageof 4